Leave Your Message
Cyclotron LB-30

Cyclotron LB-30

- The Power of Particles, Creating the Future

Cyclotron LB-30

The LB-30 series is a new-generation medium-to-high energy, high-current cyclotron developed by LBT through a decade of core technology accumulation and dedication. It enables the efficient production of a full spectrum of diagnostic and therapeutic isotopes, assisting customers in high-economy industrial production and cutting-edge nuclear medicine exploration.

Core highlights include:
• Integrated High-Current Multimode + ECR External Dual Ion Source: Significantly improves ionization and beam transmission efficiency, enabling one-stop efficient generation of H⁻, D⁻, and He²⁺ beams, ensuring stable and efficient isotope production;
• Multi-Particle Compatibility Design:Compatible with accelerating H⁻, D⁻, and He²⁺ ions, broadening the isotope production spectrum;
• Beam Extraction Energy Continuously Adjustable System: Adjusts energy without the need for degraders, balancing high isotope yield and low impurities;
• Positive Ion Internal Target Design: Efficiently produces positive ion beam-related nuclides such as 211At (He++) and 177Lu (D+).

    Empowering Commercial Operation and Frontier Exploration Multiple Beam Types, Flexible Adjustable Energy

    The LB-30 series is equipped with an integrated external Multimode/ECR dual ion source platform, enabling one-stop efficient generation of H⁻, D⁻, He++ high-current beams, covering mainstream PET/SPECT diagnostic and therapeutic nuclides.
    Coupled with the continuously variable energy beam extraction technology, it allows flexible, precise adjustment and optimization of beam energy, avoiding the use of degraders, and balancing the purity and yield of nuclide production.
    • H- 

      13-30MeV

    • D-

      7-15MeV

    • He++

      20-30MeV

    Expanding the Boundaries of Precision Diagnosis and TherapyIntegrated Multi-Scenario Application

    - As the source equipment for the aforementioned clinical applications, the LB-30 series can cover multiple application scenarios in a one-stop manner, laying a solid equipment foundation for the clinical popularization, application deepening, and frontier exploration of precision nuclear medicine diagnosis and therapy technologies.
    - In diagnosis, nuclear medicine imaging combined with molecular information enables early detection and precise typing; in therapy, radionuclide-targeted drugs physically overcome tumor resistance and heterogeneity, while precise radiotherapy utilizes various mechanisms to target and kill cancer cells, reducing damage to normal tissues.

    Production of Novel Diagnostic Radionuclides

    • 203Pb
    • 99mTc
    • 111In
    • 123I
    • 168Ge
    • 61Cu
    • 89Zr
    • 68Ga
    • 64Cu
    • 18F

    Novel Therapeutic Radionuclides

    • 211At
    • 225Ac
    • 67Cu
    • 177Lu

    BNCT Neutron Source

    • n+10B→7Li+α
    LB-30

    Customized to Meet Diverse Customer NeedsModular Product Portfolio

    We consistently focus on the diverse needs of customers, exclusively developing modular product combinations tailored to different customer groups, including:
    • Multi-Particle Type: Suitable for customers with diverse research directions and certain scientific research attributes.
    • Single-Ion High-Current Type: Suitable for customers with specific usage directions, pursuing performance for industrial production.

    Integrated Isotope Production Solution

    We deeply understand the importance of providing an overall isotope production solution. For different nuclides, we provide a complete set of nuclide production equipment and processes with fully independent intellectual property rights, helping customers achieve:
    • Automated and intelligent operation compliant with GMP regulations
    • Comprehensive nuclide coverage
    • High-standard production capacity guarantee

    Automated Process

    • Target Dissolution/Evaporation
    • Radionuclide Separation/Purification
    • Dispensing and Delivery
    • Target Preparation
    • Cyclotron Irradiation
    Integrated Isotope Production Solution

    Partial Nuclide Yields

    Diagnostic Nuclides (PET/SPECT)

    • F

      15Ci/2h

      18O (p,n) 18F

    • N-13

      400mCi/20min

      16O(p,α)13N

    • c

      3Ci/30min

      14N (p, α) 11C

    • CU-64

      7.0mCi/μAh

      64Ni (p,n) 64Cu

    • Cu-61

      600mCi/3h

      natZn(p,x)61Cu

    • GA-68

      10000mCi/1h

      68Zn(p,n)68Ga

    • ZR-89

      0.6mCi/μAh

      89Y(p,n) 89Zr

    • I-124

      0.5mCi/μAh

      124Te(p,n)124I

    • Tc-99m

      8.5mCi/μAh

      100Mo(p,2n)99mTc

    • In-111

      9.0mCi/μAh

      111Cd(p,n)111In

    • I-123

      65.0mCi/μAh

      124Xe(p,n)123Cs123Xe->123I

    Ge/Ga Generator Source Material

    • Ge-68

      0.05mCi/μAh

      natGa(p,x)68Ge

    Therapeutic Nuclides

    • Ac-225jpg

      100mCi/5d

      226Ra(p,2n)225Ac

    • At-211jpg

      300mCi/8h

      natBi(α,2n)2111At

    Comprehensive Project Solution

    Purchasing a cyclotron is only the first step in project construction. We not only provide advanced accelerator equipment but are also committed to becoming a comprehensive partner for our customers by offering a full suite of isotope production processes, equipment, and operational solutions.
    We have a professional and experienced project construction and technical support team, providing a full lifecycle solution covering project planning, compliance, construction, operation, and decommissioning.

    Contact Us

    Fill in the corresponding information, we will reply to you in the first time.